Logo
Logo

About Famotidine API

Product
  • Therapeutic CategoryGastro-Intestinal - GI

  • CAS Number

    76824-35-6

  • API Technology

    Synthetic

  • Dose Form

    Oral Solids

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted

Mechanism of Action

Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion. Both the acid concentration and volume of gastric secretion are suppressed by famotidine, while changes in pepsin secretion are proportional to volume output.

Related APIs

Esomeprazole Magnesium Trihydrate

Gastro-Intestinal - GI

arrow

Famotidine

Gastro-Intestinal - GI

arrow

Lubiprostone

Gastro-Intestinal - GI

arrow

Nizatidine

Gastro-Intestinal - GI

arrow

Omeprazole

Gastro-Intestinal - GI

arrow

Omeprazole Magnesium

Gastro-Intestinal - GI

arrow

Pantoprazole Sodium

Gastro-Intestinal - GI

arrow

Rabeprazole Sodium (Amorphous & Form Y)

Gastro-Intestinal - GI

arrow

Vonoprazan Fumarate

Gastro-Intestinal - GI

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.